Research Articles | Page 75 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) Aug 2016 Oncotarget myelodysplastic syndromes (MDS)
Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia Dec 2016 Oncotarget aplastic anemia
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy Feb 2017 Oncotarget myelodysplastic syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Health Professional Version Oct 2015 PDQ Cancer Information Summaries [Internet]
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Oct 2015 PDQ Cancer Information Summaries [Internet] myelodysplastic syndromes (MDS)
Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia Jul 2012 Pediatr Blood Cancer aplastic anemia
Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male. Jan 2012 Pediatr Blood Cancer paroxysmal nocturnal hemoglobinuria (PNH)
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC) Nov 2013 Pediatr Blood Cancer aplastic anemia
Outcomes and healthcare utilization in children and young adults with aplastic anemia: A multiinstitutional analysis Jul 2017 Pediatr Blood Cancer aplastic anemia
Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria Apr 2014 Pediatr Blood Cancer paroxysmal nocturnal hemoglobinuria (PNH)